MedPath
HSA Approval

FORLAX POWDER FOR ORAL SOLUTION 4G/SACHET

SIN17210P

FORLAX POWDER FOR ORAL SOLUTION 4G/SACHET

FORLAX POWDER FOR ORAL SOLUTION 4G/SACHET

March 25, 2025

DKSH SINGAPORE PTE. LTD.

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantDKSH SINGAPORE PTE. LTD.

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
General Sale List
HSA Singapore Classification

Formulation Information

POWDER, FOR SOLUTION

ORAL

Medical Information

A06AD15

Manufacturer Information

DKSH SINGAPORE PTE. LTD.

BEAUFOUR IPSEN INDUSTRIE

Active Ingredients

Macrogol 4000 (Polyethylene glycol 4000)

4.00g

Documents

Patient Information Leaflets

Forlax Powder for Oral Solution 4g Sachet.pdf

Approved: March 25, 2025

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

FORLAX POWDER FOR ORAL SOLUTION 4G/SACHET - HSA Approval | MedPath